Thursday, July 31, 2014
Inquirer Daily News

Archive: May, 2012

Should pharma grow, shrink or what?

Wednesday, May 30, 2012, 10:32 AM
by Daniel R. Hoffman, Ph.D. What does it say about an industry when its leading competitors appear fundamentally at odds about whether they should grow bigger, smaller, more diversified or more focused? The rosy view is that the abundance of opportunities offers multiple paths to success and the... Read more

FDA and ISMP working together help consumers prevent errors

Tuesday, May 29, 2012, 8:00 AM
by Michael R. Cohen, R.Ph. The U.S. Food and Drug Administration (FDA) and the organization I work for, the nonprofit Institute for Safe Medication Practices (ISMP), have long shared a common goal of helping consumers prevent medication errors. Now, to reach as many consumers as possible, FDA’s... Read more

Your coverage may get much better under health reform

Friday, May 25, 2012, 7:42 AM
by Robert I. Field, J.D., Ph.D. What’s the point of health insurance if it doesn’t cover much? Many policies today are so skimpy they leave patients with thousands of dollars in medical bills even after the coverage kicks in. They’re hardly worth the cost of the premiums. This... Read more

Upcoming chat: What to do about PSA testing

Thursday, May 24, 2012, 4:16 PM
Earlier this month, an influential federal panel rejected PSA (prostate-specific antigen) screening for prostate cancer, stirring controversy and raising questions. Given the trade-offs, men should stop having the screening test, which measures the level of prostate-specific antigen in the blood,... Read more

Why pharma lacks strategic perspective

Wednesday, May 23, 2012, 10:03 AM
by Daniel R. Hoffman, Ph.D. An article published last year addressed a factor generally associated with corporate failure and success. Although it mentioned the drug industry only peripherally, it says a great deal about why pharma remains stuck in its current down cycle. The article's author was... Read more

Laundry packets tempting to children

Tuesday, May 22, 2012, 10:27 AM
by Michael R. Cohen, R.Ph. I don’t usually stray too far from medication-related topics for my blogs each week. However, something crossed my desk a few days ago from the American Association of Poison Control Centers that caught my attention, and I think it’s worthwhile mentioning. The... Read more

Health reform is good for business

Friday, May 18, 2012, 10:09 AM
by Robert Field, J.D., M.P.H., Ph.D. Big business could be the biggest loser if the Supreme Court overturns Obamacare. To be more precise, one business in particular faces an enormous risk – the insurance industry. Health insurance companies could lose about $1 trillion in revenue through 2020... Read more

Pharma at the Rubicon

Wednesday, May 16, 2012, 10:01 AM
by Daniel R. Hoffman, Ph.D. One way of viewing the drug industry's current situation — underperforming the S&P 500 by more than 790 basis points this year — involves asking whether pharma possesses the innovative skill to discover and develop new offerings or, alternatively, prop up... Read more

Keeping dangerous 'toys' away from kids

Tuesday, May 15, 2012, 4:03 PM
Last October the New York Times published a story about a 13-month-old boy who died after swallowing pills from a prescription medicine bottle. His parents had given him the bottle to play with as a rattle, believing he could not open the child-resistant cap. The bottle contained Suboxone, a medicine... Read more

Mass. may lead country in health reform again

Sunday, May 13, 2012, 8:43 AM
Health care costs too much. Everyone agrees. But no one seems to know what to do about it. If Obamacare survives Supreme Court review and takes effect in 2014, it will go a long way toward reducing the number of people without insurance. But it leaves the problem of rising costs relatively untouched... Read more
About this blog

Check Up covers major health events in our region and offers everything from personal health advice to an expert look at health reform. Read about some of our bloggers here.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Also on Philly.com:
Stay Connected